Light-mediated anti-cell proliferative compositions and methods
AssigneeLa Jolla Institute for Allergy and Immunology
InventorsCarl F. Ware, Timothy C. Cheung, Theresia A. Banks
Life of this patent
Estimating the term…
Loading patent…
AssigneeLa Jolla Institute for Allergy and Immunology
InventorsCarl F. Ware, Timothy C. Cheung, Theresia A. Banks
Estimating the term…
The tumor-necrosis factor superfamily member LIGHT (p30; TNFSF-14) is a cytokine for inducing immune responses against tumors. A novel biochemical approach is used to decorate the surface of tumor cells with LIGHT. LIGHT decorated cells can be used to vaccinate and induce effective, sustained immunity against cells expressing neo or pathogen associated antigens. Variants of LIGHT are described that enhance binding to cellular receptors (e.g., LT beta receptor) and decrease regulation by inhibitors (e.g., Decoy Receptor 3) increasing ability to stimulate immunity.
A cell, said cell having an LTbeta receptor agonist attached, conjugated or coupled to the membrane of a cell.
(canceled)
-10. (canceled)
-21. (canceled)
-29. (canceled)
-33. (canceled)
-37. (canceled)
-41. (canceled)
A method of promoting, stimulating, inducing or increasing immunity against a hyperproliferative cell, tumor cell, cancer cell or metastatic cell, or pathogen infected cell comprising administering to a subject an amount of a cell having LTbeta receptor agonist attached, conjugated or coupled to the cell membrane effective to promote, stimulate, induce or increase the subject's immunity against the hyperproliferative cell, tumor cell, cancer cell, metastatic cell or pathogen infected cell.
-46. (canceled)
A method of treating a subject for undesirable or abnormal hyperproliferative cells, tumor cells, cancer cells, neoplastic cells, metastatic cells, or pathogen infected cells comprising administering to the subject an amount of a cell having LTbeta receptor agonist attached, conjugated or coupled to the cell membrane effective to treat the subject for undesirable or abnormal hyperproliferative cells, tumor cells, cancer cells, neoplastic cells, metastatic cells, or pathogen infected cells.
-121. (canceled)
Dependencies are inferred from the claim text.